Rchr
J-GLOBAL ID：200901060002775582   Update date: Jun. 18, 2024

Kiyota Naomi

キヨタ ナオミ | Kiyota Naomi
Affiliation and department：
Kobe University University Hospital Cancer Center

About Kobe University University Hospital Cancer Center


Research field  (1)： Hematology and oncology
Research theme for competitive and other funds  (15)：
  • 2023 - 2026 唾液腺癌における免疫微小環境の特徴と免疫関連バイオマーカーの探索
  • 2020 - 2023 Genetic alterations and expressions of immune check point molecules in sinonasal neuroendocrine carcinoma
  • 2019 - 2023 Clinical research in the development of patient reported outcome measures for cancer patients
  • 2017 - 2020 Genetic alterations and expressions of immune check point molecules in salivary gland cancer
  • 2014 - 2017 Exploratory analyses of immunohistochemistry pattern and genetic alterations for salivary gland cancer
Show all
Papers (275)：
  • Yoshinori Imamura, Naomi Kiyota, Makoto Tahara, Takeshi Kodaira, Ryuichi Hayashi, Hiroshi Nishino, Yukinori Asada, Hiroki Mitani, Shigemichi Iwae, Naoki Nishio, et al. Risk prediction model for cisplatin-induced acute kidney injury in patients with head and neck cancer receiving chemoradiotherapy: A re-analysis of a phase II/III JCOG1008 trial. Oral oncology. 2024. 154. 106868-106868
  • Katherine J Taylor, Cecilie D Amdal, Kristin Bjordal, Guro L Astrup, Bente B Herlofson, Fréderic Duprez, Ricardo R Gama, Alexandre Jacinto, Eva Hammerlid, Melissa Scricciolo, et al. Long-term health-related quality of life in head and neck cancer survivors: A large multinational study. International journal of cancer. 2024. 154. 10. 1772-1785
  • Satoshi Seno, Kazuma Iwashita, Akifumi Kajiwara, Rie Sasaki, Tatsuya Furukawa, Masanori Teshima, Hirotaka Shinomiya, Kiyota N, Rod Lynch, Kenji Yoshida, et al. Targeting Anterior Commissure Involvement with Hyperfractionated Radiotherapy for T1-T2 Squamous Cell Carcinoma of the Glottic Larynx. Cancers. 2024
  • Makoto Tahara, Naomi Kiyota, Hiroo Imai, Shunji Takahashi, Akihiro Nishiyama, Shingo Tamura, Yasushi Shimizu, Shigenori Kadowaki, Ken-Ichi Ito, Masahiro Toyoshima, et al. A Phase 2 Study of Encorafenib in Combination with Binimetinib in Patients with Metastatic BRAF-Mutated Thyroid Cancer in Japan. Thyroid : official journal of the American Thyroid Association. 2024
  • Naomi Kiyota, Makoto Tahara, Akihiro Homma. Current status and future perspective of postoperative treatment for locally advanced squamous cell carcinoma of the head and neck. Japanese Journal of Clinical Oncology. 2024
ｍore...
MISC (178)：
  • 花房 宏昭, 田中 敬子, 濱 真奈美, 金原 史朗, 益子 尚久, 坊 亮輔, 國久 智成, 粟野 宏之, 清田 尚臣, 久保 亮治, et al. がんゲノムプロファイル検査でRAD51Dが検出され、事前のリスク低減卵管卵巣摘出術についての情報交換が有用であった症例. 日本遺伝カウンセリング学会誌. 2023. 44. 2. 139-139
  • 能勢 拓, 清田 尚臣. 【肺がん・頭頸部がん】頭頸部がんに対する化学放射線療法. 腫瘍内科. 2022. 30. 6. 671-676
  • 清田 尚臣. 【実地医家が知っておくべきがんの薬物療法 がんの薬物療法の必要性・重要性】各がん種の最新情報と知っておくべき標準治療 頭頸部がん. Medical Practice. 2022. 39. 10. 1457-1461
  • 金原 史朗, 清田 尚臣. がんゲノム医療時代と生物学的製剤・分子標的治療薬. 耳鼻咽喉科. 2022. 2. 3. 372-376
  • 清田 尚臣. 【分子標的薬と耳鼻咽喉科】分子標的薬の今後の展開. JOHNS. 2021. 37. 12. 1551-1553
ｍore...
Books (19)：
  • 頭頸部がん薬物療法ハンドブック
    中外医学社 2021 ISBN:9784498022881
  • 新臨床腫瘍学 : がん薬物療法専門医のために
    南江堂 2021 ISBN:9784524227396
  • 頭頸部がん薬物療法ガイダンス / 頭頸部がん薬物療法ガイダンス
    金原出版株式会社 2018
  • 新臨床腫瘍学 / 41 内分泌がん
    南江堂 2018
  • 頭頸部癌診療ガイドライン2018年版 / 頭頸部癌診療ガイドライン2018年版
    金原出版株式会社 2017
ｍore...
Lectures and oral presentations  (233)：
  • シスプラチン併用化学放射線療法の現状とこれから:術後シスプラチン併用化学放射線療法
    (第47回日本頭頸部癌学会 2023)
  • Darolutamide for patients with androgen receptor positive salivary gland cancers (DISCOVARY): The results of phase 2 study of darolutamide monotherapy
    (ASCO2023 2023)
  • A phase II trial of nivolumab for patients with platinum-refractory recurrent or metastatic salivary gland cancer.
    (ASCO2023 2023)
  • A risk prediction model for cisplatin-induced acute kidney injury in head and neck cancer patients who receive chemoradiotherapy: A supplement analysis of a phase II/III trial of JCOG1008
    (ASCO2023 2023)
  • Impact of acute kidney injury on overall survival in postoperative patients with head and neck cancer who received chemoradiotherapy with cisplatin: A supplementary analysis of a phase II/III trial of JCOG1008
    (ASCO2023 2023)
ｍore...
Education (1)：
  • - 1999 Kobe University School of Medicine Faculty of Medicine
Professional career (2)：
  • 学士(医学) (神戸大学)
  • 博士(医学) (神戸大学)
Awards (2)：
  • 2020/12 - JCOG Shimoyama Masanori Award
  • 2014/12 - JCOGデータセンター Best Study Coordinator賞 JCOG研究者
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page

TOP

BOTTOM